Author

Jonathan Eintracht

Hebrew University of JerusalemORCID 0000-0002-7565-4071Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

A Saleh· 1 shared Alexey Obolensky· 1 shared Asodu Sandeep SarmaiD· 1 shared Chen MatsevichiD· 1 shared Dror SharoniD· 1 shared Dulce Lima CunhaiD· 1 shared Eyal BaniniD· 1 shared Hajrah Sarkar· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

A Saleh

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single anticodon-edited tRNA therapy targeting highly prevalent Arg>Ter premature termination codons causing inherited retinal diseases

Asodu Sandeep Sarma, A Saleh, Jonathan Eintracht, Hala Kamal, Samer Khetab, Manar Salameh, Chen Matsevich, Alexey Obolensky, Eyal Banin, Dror Sharon

This paper develops a single therapeutic molecule targeting the most common class of nonsense variants in inherited retinal diseases using anticodon-edited tRNA.

bioRxiv · Jul 23, 2026 · PreprintGenetics

Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs

Dulce Lima Cunha, Hajrah Sarkar, Jonathan Eintracht, Philippa Harding, Huiqing Zhou, Mariya Moosajee

This study uses patient iPSC-derived models to test TRIDs for restoring PAX6 function in aniridia, identifying amlexanox as effective in increasing PAX6 levels and rescuing disease phenotypes.

Molecular Therapy — Nucleic Acids · Jun 26, 2023Peer-reviewedGenetics